» Articles » PMID: 15517303

[Panzytopenia from Combination Therapy with Azathioprin and Allopurinol]

Overview
Journal Z Rheumatol
Publisher Springer
Specialty Rheumatology
Date 2004 Nov 2
PMID 15517303
Authors
Affiliations
Soon will be listed here.
Abstract

Azathioprine has been used in rheumatology for more than twenty years. Indications are collagen diseases with multiorgan involvement, where co-medications are frequently necessary. We describe a patient suffering from pancytopenia following a combination therapy of azathioprine and allopurinol because of lupus erythematodes and diabetic nephropathy with hyperuricemia.

References
1.
Chan G, Erdmann G, Gruber S, Matas A, Canafax D . Azathioprine metabolism: pharmacokinetics of 6-mercaptopurine, 6-thiouric acid and 6-thioguanine nucleotides in renal transplant patients. J Clin Pharmacol. 1990; 30(4):358-63. DOI: 10.1002/j.1552-4604.1990.tb03606.x. View

2.
Weinshilboum R . Methylation pharmacogenetics: thiopurine methyltransferase as a model system. Xenobiotica. 1992; 22(9-10):1055-71. DOI: 10.3109/00498259209051860. View

3.
Sandborn W . Azathioprine: state of the art in inflammatory bowel disease. Scand J Gastroenterol Suppl. 1998; 225:92-9. DOI: 10.1080/003655298750027290. View

4.
Stockhausen G, Hopf U, GLOGNER P . [Pancytopenia following a combination therapy with allopurinol and azathioprine. Discussion contribution and conclusion]. Med Welt. 1977; 28(4):198. View

5.
Kennedy D, Hayney M, Lake K . Azathioprine and allopurinol: the price of an avoidable drug interaction. Ann Pharmacother. 1996; 30(9):951-4. DOI: 10.1177/106002809603000906. View